<DOC>
	<DOCNO>NCT01939301</DOCNO>
	<brief_summary>This randomize , double blind study treat subject diagnose pulmonary embolism inhale nitrix oxide . In clinical trial investigator randomize patient receive inhale nitric oxide sham ( nitrogen + oxygen ) 24 hour . Patients must submassive pulmonary embolism ( PE ) evidence right ventricular ( RV ) heart dysfunction . Investigators hypothesize administration inhale NO + oxygen patient severe submassive PE improve RV function , reduce RV strain necrosis improve dyspnea ( difficulty breathe ) sham oxygen treatment .</brief_summary>
	<brief_title>Nitric Oxide Treat Pulmonary Embolism</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Age &gt; /= 18 Pulmonary imagingproven PE , interpret local radiologist At least one predictor RV dysfunction : 1. echocardiography RV dilation hypokinesis , 2. estimate RVSP &gt; 40mm HG , 3 . RV &gt; LV CTPA , 4. elevate troponin I ( &gt; 0.1 ng/mL ) natriuretic peptide ( BNP &gt; 90 pg/mL ) , 5. screen bedside cardiac ultrasound color flow capability show RV dysfunction , 6 . RV strain ECG Plan admit bed telemetry capability Vasopressor support time enrollment Pregnancy Plan clinical care team use lytic surgical embolectomy Plan clinical team use platelet inhibit drug Contraindication anticoagulation Altered mental status patient unable provide inform consent Inability use nasal cannula face mask Comfort care measure institute Supplemental oxygen requirement great administer via nasal cannula order maintain Sa ) 2 &gt; 80 % Pneumothorax decompression Serum MetHb &gt; 10 % Recent use drug know increase cGMP Use nitroprusside nitroglycerin within last 4 hour Use nitrate past 24 hour Use fibrinolytic medicine within past 14 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pulmonary embolism clot</keyword>
</DOC>